Clinical correlations and pulmonary function at 8 years of age after severe neonatal respiratory failure

Carina M Majaesic1, Richard Jones, Irina A Dinu

  • 1Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. CarinaMajaesic@cha.ab.ca

Pediatric Pulmonology
|July 27, 2007
PubMed

Insights

Severe neonatal respiratory failure survivors often experience reduced lung function. Congenital diaphragmatic hernia and extracorporeal membrane oxygenation increase the risk of poorer pulmonary outcomes in these children.

Area of Science:

  • Pediatric Pulmonology
  • Neonatal Intensive Care
  • Respiratory Medicine

Background:

  • Severe neonatal respiratory failure poses significant risks to long-term lung health.
  • Understanding the pulmonary sequelae is crucial for appropriate patient management and follow-up.

Purpose of the Study:

  • To investigate the pulmonary outcomes in survivors of severe neonatal respiratory failure.
  • To identify risk factors associated with adverse pulmonary sequelae.

Main Methods:

  • A multicenter, prospective study involving 54 survivors of neonatal respiratory failure.
  • Pulmonary function testing (spirometry, lung volumes) was conducted at 8 years of age.
  • Univariate analysis was used to determine risk factors for adverse outcomes.

Main Results:

  • Mean forced vital capacity (FVC) and forced expiratory volume (FEV1) were reduced in the cohort.
  • 54% of subjects had normal spirometry, while 19% showed airflow obstruction and 27% reduced FVC.
  • Poorer outcomes were linked to congenital diaphragmatic hernia (CDH), extracorporeal membrane oxygenation (ECMO), low birth weight for gestational age, prolonged hospitalization, and need for oxygen.

Conclusions:

  • Neonates with severe respiratory failure, particularly those with CDH or treated with ECMO, are at higher risk for impaired pulmonary function.
  • These high-risk infants require close monitoring and follow-up to manage potential long-term respiratory issues.
Abstract

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...